Skip to content

Drug interactions

Empagliflozin-linagliptin + Tipranavir

Severity: Moderate

Empagliflozin-linagliptin and Tipranavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tipranavir with ritonavir has mixed CYP3A4 and P-gp effects, and net effects on linagliptin may increase exposure. Linagliptin has a wide therapeutic margin, so the effect is usually modest.

What this interaction means in plain words

Empagliflozin-linagliptin and Tipranavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Empagliflozin-linagliptin belongs to Endocrine; Tipranavir belongs to Anti Virals.

Evidence level: Low

Why it happens

Net effects of tipranavir/ritonavir on CYP3A4 and P-gp alter the metabolism and efflux of linagliptin.

What to do

No empirical dose change is needed; monitor blood glucose and adverse effects when starting or stopping the antiretroviral.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Tipranavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin-linagliptin with Tipranavir?

MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Tipranavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tipranavir with ritonavir has mixed CYP3A4 and P-gp effects, and net effects on linagliptin may increase exposure. Linagliptin has a wide therapeutic margin, so the effect is usually modest.

How serious is the interaction between Empagliflozin-linagliptin and Tipranavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed; monitor blood glucose and adverse effects when starting or stopping the antiretroviral.

What other medicines interact with Empagliflozin-linagliptin?

MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in